Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002008775-24-000001
Filing Date
2024-01-19
Accepted
2024-01-19 16:46:37
Documents
1
Effectiveness Date
2024-01-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6288
  Complete submission text file 0002008775-24-000001.txt   7354
Mailing Address 135 MISSISSIPPI STREET SAN FRANCISCO CA 94107
Business Address 135 MISSISSIPPI STREET SAN FRANCISCO CA 94107 310-463-6172
Montara Therapeutics, Inc. (Filer) CIK: 0002008775 (see all company filings)

EIN.: 921127857 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-502979 | Film No.: 24546188